156. レット症候群 Rett syndrome Clinical trials / Disease details

臨床試験数 : 44 / 薬物数 : 61 - (DrugBank : 23) / 標的遺伝子数 : 57 - 標的パスウェイ数 : 83

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02023424 (ClinicalTrials.gov)	January 2014	23/12/2013	An Open Label, Exploratory Study to Investigate the Treatment Effect of GlatiramerAcetate on Girls W ...	An Open Label, Exploratory Study to Investigate the Treatment Effect og GlatiramerAcetate (Copaxone ...	Rett Syndrome	Drug: Glatiramer Acetate (Copaxone®)	Sheba Medical Center	NULL	Recruiting	6 Years	15 Years	Female	10	Phase 1	Israel
2	NCT02153723 (ClinicalTrials.gov)	August 2013	26/5/2014	Pharmacological Treatment of Rett Syndrome With Glatiramer Acetate (Copaxone)	Pharmacological Treatment of Rett Syndrome With Glatiramer Acetate (Copaxone)	Rett Syndrome	Drug: Glatiramer Acetate	Montefiore Medical Center	Rett Syndrome Research Trust	Completed	10 Years	N/A	Female	10	Phase 2	United States

First Previous1Next Last